Antihistamines Flashcards
Cyclizine
H1 antihistamine
First Generation Antihistamine
SLIGHT Sedation
Used in MOTION SICKNESS/Emesis
Cetirizine
H1 antihistamine
Second Generation antihistamine
Highly selective for H1 sites
Few anti-cholinergic side effects
Penetrate poorly into CNS, reducing sedative effects
Dimenhydrinate
First Generation Antihistamine
HIGH SEDATION effect
Used to treat motion sickness
Diphenhydramine
First Generation Antihistamine
HIGH SEDATION
USED to treat MOTION SICKNESS
Used in Non-H1 effects for LOCAL ANESTHESIA
Fexofenadine
H1 Antihistamine
Second Generation antihistamine
LOW SEDATION
- highly selective for H1 sites and have few anti-cholinergic side effects
- Penetrate poorly into CNS, reducing sedative effects
Loratadine
H1 antihistamine
Second Generation antihistamine
LOW Sedation
- High selectivity for H1 sites and have few anti-cholinergic side effects
- Penetrate poorly into the CNS, reduce sedative effects
Promethazine
H1 antihistamine
Used in treatment of Motion sickness/emesis
- Very Effective
Used as local anesthetic by BLOCKING SODIUM CHANNELS
Causes SEDATION
- Used as antiemetic
Adalimumab
Anti-TNF alpha
HUMAN antibody to TNF alpha
- Mechanism: binds TNF to prevent interaction with receptor
- Reduces circulating and localized levels of TNF
Application:
- Inflammatory disease involving TNF
- Parenteral Administration required
- Rh ART, used in COMBO with METHOTREXATE
- Elevated TNF in joints
- Crohn’s disease, used in COMBO with AZATHIOPRINE
- Elevated TNF in stool
Complications
- Increased frequency of infections (upper respiratory, urinary)
Etanercept
Anti-TNF agent
Fusion protein containing:
- Ligand binding domain of TNF receptor
- and Fc domain of IgG
Mechanism:
- Bind to TNF alpha binding domain to prevent interaction with receptor
Applications:
- Parenteral administration required
- Rh arthritis, used in combo with methotrexate
- Crohn’s disease, used in combo with azathioprine
Complications:
- increased frequency of infections (upper respiratory, urinary)
Infliximab
Anti-TNF alpha agent
Humanized antibody to TNF
Binds to TNF alpha
- Prevents interaction with receptor
- reduces circulating and localized levels of TNF
Applications:
- Parenteral administration required
- Rh, used in combo with methotrexate
- Crohn’s disease, used in combo with azathioprine
Complications
- Increased frequency of infections (upper respiratory, urinary)
Anakinra
Anti-IL-1 Agent
Competitive IL-1 R antagonist
Useful in treating Rh ART
- Possibly other inflammatory diseases
Short half life, daily injection required
Increased susceptibility to infection
Tofacitinib
Jak kinase inhibitor
Treatment in Rh ART
Administration: Oral
Second line treatment for Rh ART
Mechanism:
- Inhibits all activity of cytokines required for adaptive immunity (IL-2, 4)
- Inhibits activities of inflammatory cytokines: IL-
THERAPEUTIC DOSE: 5 mg bid (twice a day)
- Higher doses to produce potent immunosuppression AND adverse effects
Adverse effects:
- Anemia, neutropenia, general myelosuppression
- Increase risk of infection (herpes zoster)
Effect: Comparable to anti TNF in reducing active disease in Rh ART
Aspirin
Nonselective COX inhibitor
Prototypical NSAID inhibits COX-1 and COX-2
- IRREVERSIBLY inhibits COX enzymes
- Only NSAID with cardiovascular protective effects
Irreversibly inhibits COX-1 so no TXA2 for life of platelet (7-10 days)
Rapidly converted to salicylic acid
- Main portion of aspirin is acetyl group that acts as a acetyl group to permanently inhibit COX
All metabolites excreted in urine
- If elimination saturates beyond 600 mg, total body load and half life increase to 12-16 hours from 3-5
Selectivity (IC50): 4.4
- IC50 is (COX-2/COX-1):
- IC50 COX-1: 1.7
- IC 50 COX-2: 7.5
Analgesic/antipyretic
Cardiovascular prophylaxis
- Due to reduced platelet aggregation
Intolerance:
- SALICYLISM: Hypersensitivy to ASA
- Hyperventilation, tinnitus, vertigo, emesis, sweating
- Reye’s Syndrome: Associated with ASA and other salicylates used in children with viral illness
- Acute encephalopathy, fatty liver degeneration
- Associated with viral diseases and viral vaccines
Adverse effects: - Dyspepsia: upper abdominal pain, bloating, nausea - 35% chronic NSAID users - Ulcers - 16 % chronic NSAID users - Gastric more common than duodenal - Risk factors: - Greater than 65 - High dose - Helicobacter pylori - Alcohol consumption GI Bleeding
Prevention of Adverse effects:
- H2 receptor antagonist
- Proton pump inhibitor
- MISOPROSTOL
Diclofenac
Nonselective COX inhibitor
Selectivity: 0.3
- Used in Rh ART
Diclofenac with Misoprostol
Nonselective COX inhibitor
Selective: 0.3
- Used in Rx arthritis and anti-inflammatory